Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Rectify Unveils Preclinical Data on RTY-406 for Rare Liver Disease Care
At the EASL 2026 Congress, Rectify Pharmaceuticals shared promising preclinical data for RTY-406, a novel treatment for Primary Sclerosing Cholangitis.
Industry Confidence in FDA Hinges on Stable CBER and CDER Leadership Roles
Experts warn that FDA's significant leadership turnover and reliance on acting directors at CDER and CBER may challenge regulatory predictability and trust.
Unveils Next-Gen AI Imaging Solution for Clinical Trials at ASCO
Medidata announces a new AI-powered imaging solution at ASCO 2026, offering unprecedented speed, >97% accuracy, and QC to accelerate clinical trials.
FDA Approves Datroway as First-Line Therapy for Triple Negative Cancer
AstraZeneca and Daiichi's Datroway receives FDA approval as a first-line targeted therapy for triple-negative breast cancer, outperforming chemotherapy.
AI-Guided Drug Search Identifies Folic Acid for Diabetic Wound Healing
NUS researchers combined AI and molecular simulations to identify folic acid as a promising treatment for diabetic wound healing, saving significant time.
FDA Grants Priority Review: Finerenone for CKD in Type 1 Diabetes Care
The FDA has granted priority review to Bayer’s finerenone for chronic kidney disease in adults with type 1 diabetes based on positive FINE-ONE trial data.
FDA Grants Breakthrough Designation to TOBY's Urine-Based Alzheimer Test
TOBY Inc. secures FDA Breakthrough Device Designation for its non-invasive, urine-based Alzheimer's diagnostic test utilizing VOCs and machine learning.
Europe Approves AstraZeneca's Camizestrant After FDA Advisory Rejection
Europe’s CHMP recommends AstraZeneca’s camizestrant for ER+/HER2- advanced breast cancer with ESR1 mutations, following a recent FDA committee rejection.
Asthma Drug Montelukast Shows Promise Fighting Highly Aggressive Cancers
Preclinical studies from Northwestern Medicine reveal that the common asthma drug montelukast can help treat aggressive cancers by blocking CysLTR1.
KLN-1010 Multiple Myeloma Clinical Trial Begins Dosing Patients in US
The Phase 1 inMMyCAR trial has officially begun dosing US patients with relapsed or refractory multiple myeloma using the experimental therapy KLN-1010.
Oral Namodenoson for Pancreatic Cancer to Advance into Phase 2b Trial
Can-Fite Biopharma advances oral namodenoson (CF102) to a Phase 2b trial for advanced pancreatic cancer following highly encouraging early study results.
Merck's Sacituzumab Tirumotecan Bests Chemo in Endometrial Cancer Trial
Merck’s Phase 3 TroFuse-005 trial shows sac-TMT significantly outperforms standard chemotherapy in advanced endometrial cancer, improving survival rates.
3
4
5
6
7
8
9
10
11
